Association of Acromegaly and Central Sleep Apnea Syndrome

Objective & Hypothesis:Acromegaly is usually characterized by the excessive secretion of growth hormone (GH) after the closure of epiphyseal plaques, resulting from functional pituitary adenomas.

📊

Key Findings & Data:The most common manifestations of acromegaly are acral and soft tissue overgrowth, diabetesmellitus, hypertension, and heart and respiratory failure.

💡

Conclusion & Impact:We believe that it is necessary to perform effective treatments by examining respiratorydisorders in sleep.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Özet

Acromegaly is usually characterized by the excessive secretion of growth hormone (GH) after the closure of epiphyseal plaques, resulting from functional pituitary adenomas. The most common manifestations of acromegaly are acral and soft tissue overgrowth, diabetesmellitus, hypertension, and heart and respiratory failure. In patients, obstruction of the upper airway may develop due to enlargementof the tongue and thickening of the tissues of the larynx; consequently, obstructive sleep apnea syndrome (OSAS) occurs commonly inacromegaly. Previous studies have shown an association between acromegaly and central sleep apnea syndrome (CSAS). Some of thesedescribed patients described showed that an elevation in the GH level may cause a defect in the respiratory drive. Most systemic diseasesseen in acromegaly require effective treatment. We believe that it is necessary to perform effective treatments by examining respiratorydisorders in sleep.

🔖

Cite This Article

PAZARLI, A. C., KÖSEOĞLU, H. İ., KUTLUTÜRK, F., GÖKÇE, E. (2019). Association of Acromegaly and Central Sleep Apnea Syndrome. Turkish Thoracic Journal, Cilt: 20 - Sayı: 2, 157–159. https://ajindex.com/articles/418017

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Chanson P, Salenave S. Acromegaly.Orphanet J Rare Dis 2008;3:17. [CrossRef] 2. Hernández-Gordillo D, Ortega-Gómez Mdel R, Galicia-Polo L, et al. Sleep apnea in patients with acromegaly. Frequency, characterization and positive pressure titration. Open Respir Med 2012;6:28-33. [CrossRef] 3. Vannucci L, Luciani P, Gagliardi E, et al. Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest 2013;36:237-42. 4. Colao A, Ferone D, Marzullo P, et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102-52. [CrossRef] 5. Grunstein RR, Ho KY, Berthon-Jones M, et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994;150:496-502. [CrossRef] 6. Akkoyunlu ME, Yakar F. Acromegaly and sleep disordered breathing. J Sleep Disord Ther 2013;2:5. 7. Chemla D, Attal P, Maione L, et al. Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. J Clin Endocrinol Metab 2014;99:2925-31. [CrossRef] 8. Kent BD, McNicholas WT, Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis 2015;7:1343-57. 9. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apneahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.[CrossRef]